HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

CSE1L, DIDO1 and RBM39 in colorectal adenoma to carcinoma progression.

AbstractBACKGROUND:
Gain of chromosome 20q is an important factor in the progression from colorectal adenomas to carcinomas. Genes that drive 20q gain are expected to show correlation of mRNA and protein expression levels with 20q DNA copy number status while functionally influencing cancer processes. CSE1L, DIDO1 and RBM39 are located on the 20q amplicon and affect processes such as cell viability and anchorage-independent growth in colorectal cancer. This study aimed to investigate whether CSE1L, DIDO1 and RBM39 may drive 20q amplification.
METHODS:
Protein expression levels were examined by immunohistochemical evaluation of tissue microarrays containing a series of colorectal adenoma and carcinoma samples, which were characterized by genome-wide (microarray-based) DNA and mRNA profiling.
RESULTS:
CSE1L, DIDO1 and RBM39 mRNA expression levels correlated with chromosome 20q DNA copy number status. CSE1L protein expression was not associated with 20q gain, although its expression was increased in carcinomas compared to adenomas. DIDO1 and RBM39 protein expression was quite strong in the majority of tumors irrespective of 20q DNA copy number status.
CONCLUSION:
The lack of correlation between protein expression levels and 20q DNA copy number status implies that CSE1L, DIDO1 and RBM39 are merely passengers rather than drivers of chromosome 20q gain in colorectal adenoma-to-carcinoma progression.
AuthorsAnke H Sillars-Hardebol, Beatriz Carvalho, Jeroen A M Beliën, Meike de Wit, Pien M Delis-van Diemen, Marianne Tijssen, Mark A van de Wiel, Fredrik Pontén, Gerrit A Meijer, Remond J A Fijneman
JournalCellular oncology (Dordrecht) (Cell Oncol (Dordr)) Vol. 35 Issue 4 Pg. 293-300 (Aug 2012) ISSN: 2211-3436 [Electronic] Netherlands
PMID22711543 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Cellular Apoptosis Susceptibility Protein
  • DIDO1 protein, human
  • DNA-Binding Proteins
  • HCC1 autoantigen
  • Nuclear Proteins
  • RNA, Messenger
  • RNA-Binding Proteins
Topics
  • Adenoma (genetics, metabolism, pathology)
  • Carcinoma (genetics, metabolism, pathology)
  • Cellular Apoptosis Susceptibility Protein (genetics, metabolism)
  • Chromosome Aberrations
  • Chromosomes, Human, Pair 20 (genetics)
  • Colorectal Neoplasms (genetics, metabolism, pathology)
  • DNA-Binding Proteins (genetics, metabolism)
  • Disease Progression
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Immunohistochemistry
  • Nuclear Proteins (genetics, metabolism)
  • RNA, Messenger (genetics, metabolism)
  • RNA-Binding Proteins (genetics, metabolism)
  • Reverse Transcriptase Polymerase Chain Reaction
  • Tissue Array Analysis

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: